Severely ill COVID-19 patients may need multiple medications delivered by infusion pumps. Manufacturers and hospitals are planning on how to avoid shortages of these pumps and the associated tubing.

[Image from Institute for Safe Medication Practices]
Among them are machines that are ubiquitous throughout any hospital — “smart” infusion pumps that are programmed to deliver controlled doses of medication. The effects of COVID-19 on patients’ organs heighten the need for these pumps — made by companies including Becton Dickinson (NYSE:BDX), B. Braun, Baxter (NYSE:BAX), ICU Medical (NSDQ:ICUI) and Ivenix.
Get the full story on our sister site, Medical Design & Outsourcing.
Tell Us What You Think!